APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cefprozil

Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.

Selected research

Industry Growth & Trends

Global Cefprozil Industry Growth and Trends Forecast to 2032

Report ID 173976000121 December 2025115 pages

Choose your research edition.

Industry ResearchCefprozil Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Cefprozil Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Cefprozil Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cefprozil Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Cefprozil Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

Cefprozil is a semi-synthetic broad-spectrum cephalosporin antibiotic, and it is a second-generation cephalosporin type antibiotic. It can be used to treat bronchitis, ear infections, skin infections, and other bacterial infections. It comes as a tablet and as a liquid suspension.

Global Cefprozil key players include Orchid, Taj Pharma, Dhanuka, Qilu Antibiotics, Dongying Pharma, etc. Global top five manufacturers hold a share over 45%.

India is the largest market, with a share about 50%, followed by China, and Europe, both have a share about 40 percent.

Read the full market overview

In terms of product, Anhydrous is the largest segment, with a share over 60%. And in terms of application, the largest application is Uncomplicated Skin, followed by Pharyngitis or tonsillitis, Secondary Bacterial Infection, Acute Sinusitis, etc.

Report Scope

This report provides a structured, data-driven view of the global Cefprozil market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cefprozil market size, estimates, and forecasts are presented in terms of sales volume (T) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cefprozil market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cefprozil.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cefprozil market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cefprozil Market by Company

Orchid

Taj Pharma

Dhanuka

Lupin

Alkem

Corden Pharma

Aurobindo

Covalent

TEVA GROUP

Hetero Drugs

Qilu Antibiotics

Dongying Pharma

Union Chempharma

Huafangpharm

Topfond

Cefprozil Segment by Type

Anhydrous

Monohydrate

Cefprozil Segment by Application

Pharyngitis or tonsillitis

Otitis Media

Acute Sinusitis

Secondary Bacterial Infection

Uncomplicated Skin

Other

Cefprozil Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cefprozil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cefprozil and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cefprozil.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cefprozil manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cefprozil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Anhydrous Table 2. Major Company of Monohydrate Table 3. Global Cefprozil Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cefprozil Sales by Type (2021-2026) & (T) Table 5. Global Cefprozil Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cefprozil Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cefprozil Sales Market Share in Value by Type (2021-2026) Table 8. Global Cefprozil Price by Type (2021-2026) & (USD/Kg) Table 9. Global Cefprozil Sales by Type (2027-2032) & (T) Table 10. Global Cefprozil Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cefprozil Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cefprozil Sales Market Share in Value by Type (2027-2032) Table 13. Global Cefprozil Price by Type (2027-2032) & (USD/Kg) Table 14. North America Cefprozil Sales by Type (2021-2026) & (T) Table 15. North America Cefprozil Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cefprozil Sales by Type (2021-2026) & (T) Table 17. Europe Cefprozil Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cefprozil Sales by Type (2021-2026) & (T) Table 19. Asia-Pacific Cefprozil Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cefprozil Sales by Type (2021-2026) & (T) Table 21. Latin America Cefprozil Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cefprozil Sales by Type (2021-2026) & (T) Table 23. Middle East and Africa Cefprozil Sales by Type (2021-2026) & (US$ Million) Table 24. Cefprozil Industry Trends Table 25. Cefprozil Industry Drivers Table 26. Cefprozil Industry Opportunities and Challenges Table 27. Cefprozil Industry Restraints Table 28. Global Cefprozil Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cefprozil Revenue Market Share by Company (2021-2026) Table 30. Global Cefprozil Sales by Company (2021-2026) & (T) Table 31. Global Cefprozil Sales Share by Company (2021-2026) Table 32. Global Cefprozil Market Price by Company (2021-2026) & (USD/Kg) Table 33. Global Cefprozil Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cefprozil Major Company Production Sites and Headquarters Table 35. Global Cefprozil Company, Product Type & Application Table 36. Global Cefprozil Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cefprozil by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cefprozil Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cefprozil Sales by Region (2021-2026) & (T) Table 41. Global Cefprozil Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cefprozil Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cefprozil Sales Market Share in Value by Region (2021-2026) Table 44. Global Cefprozil Sales (T), Value (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 45. Global Cefprozil Sales by Region (2027-2032) & (T) Table 46. Global Cefprozil Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cefprozil Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cefprozil Sales Market Share in Value by Region (2027-2032) Table 49. Global Cefprozil Sales (T), Value (US$ Million), Price (USD/Kg) and Gross Margin (2027-2032) Table 50. Global Cefprozil Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cefprozil Sales by Application (2021-2026) & (T) Table 52. Global Cefprozil Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cefprozil Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cefprozil Sales Market Share in Value by Application (2021-2026) Table 55. Global Cefprozil Price by Application (2021-2026) & (USD/Kg) Table 56. Global Cefprozil Sales by Application (2027-2032) & (T) Table 57. Global Cefprozil Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cefprozil Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cefprozil Sales Market Share in Value by Application (2027-2032) Table 60. Global Cefprozil Price by Application (2027-2032) & (USD/Kg) Table 61. North America Cefprozil Sales by Application (2021-2026) & (T) Table 62. North America Cefprozil Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cefprozil Sales by Application (2021-2026) & (T) Table 64. Europe Cefprozil Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cefprozil Sales by Application (2021-2026) & (T) Table 66. Asia-Pacific Cefprozil Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cefprozil Sales by Application (2021-2026) & (T) Table 68. Latin America Cefprozil Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cefprozil Sales by Application (2021-2026) & (T) Table 70. Middle East and Africa Cefprozil Sales by Application (2021-2026) & (US$ Million) Table 71. Orchid Company Information Table 72. Orchid Business Overview Table 73. Orchid Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 74. Orchid Cefprozil Product Portfolio Table 75. Orchid Recent Development Table 76. Taj Pharma Company Information Table 77. Taj Pharma Business Overview Table 78. Taj Pharma Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 79. Taj Pharma Cefprozil Product Portfolio Table 80. Taj Pharma Recent Development Table 81. Dhanuka Company Information Table 82. Dhanuka Business Overview Table 83. Dhanuka Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 84. Dhanuka Cefprozil Product Portfolio Table 85. Dhanuka Recent Development Table 86. Lupin Company Information Table 87. Lupin Business Overview Table 88. Lupin Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 89. Lupin Cefprozil Product Portfolio Table 90. Lupin Recent Development Table 91. Alkem Company Information Table 92. Alkem Business Overview Table 93. Alkem Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 94. Alkem Cefprozil Product Portfolio Table 95. Alkem Recent Development Table 96. Corden Pharma Company Information Table 97. Corden Pharma Business Overview Table 98. Corden Pharma Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 99. Corden Pharma Cefprozil Product Portfolio Table 100. Corden Pharma Recent Development Table 101. Aurobindo Company Information Table 102. Aurobindo Business Overview Table 103. Aurobindo Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 104. Aurobindo Cefprozil Product Portfolio Table 105. Aurobindo Recent Development Table 106. Covalent Company Information Table 107. Covalent Business Overview Table 108. Covalent Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 109. Covalent Cefprozil Product Portfolio Table 110. Covalent Recent Development Table 111. TEVA GROUP Company Information Table 112. TEVA GROUP Business Overview Table 113. TEVA GROUP Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 114. TEVA GROUP Cefprozil Product Portfolio Table 115. TEVA GROUP Recent Development Table 116. Hetero Drugs Company Information Table 117. Hetero Drugs Business Overview Table 118. Hetero Drugs Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 119. Hetero Drugs Cefprozil Product Portfolio Table 120. Hetero Drugs Recent Development Table 121. Qilu Antibiotics Company Information Table 122. Qilu Antibiotics Business Overview Table 123. Qilu Antibiotics Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 124. Qilu Antibiotics Cefprozil Product Portfolio Table 125. Qilu Antibiotics Recent Development Table 126. Dongying Pharma Company Information Table 127. Dongying Pharma Business Overview Table 128. Dongying Pharma Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 129. Dongying Pharma Cefprozil Product Portfolio Table 130. Dongying Pharma Recent Development Table 131. Union Chempharma Company Information Table 132. Union Chempharma Business Overview Table 133. Union Chempharma Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 134. Union Chempharma Cefprozil Product Portfolio Table 135. Union Chempharma Recent Development Table 136. Huafangpharm Company Information Table 137. Huafangpharm Business Overview Table 138. Huafangpharm Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 139. Huafangpharm Cefprozil Product Portfolio Table 140. Huafangpharm Recent Development Table 141. Topfond Company Information Table 142. Topfond Business Overview Table 143. Topfond Cefprozil Sales (T), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2021-2026) Table 144. Topfond Cefprozil Product Portfolio Table 145. Topfond Recent Development Table 146. North America Cefprozil Market Size Growth Rate (CAGR) by Country (T): 2021 VS 2025 VS 2032 Table 147. North America Cefprozil Sales by Country (2021-2026) & (T) Table 148. North America Cefprozil Sales Market Share by Country (2021-2026) Table 149. North America Cefprozil Sales Forecast by Country (2027-2032) & (T) Table 150. North America Cefprozil Sales Market Share Forecast by Country (2027-2032) Table 151. North America Cefprozil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. North America Cefprozil Market Size by Country (2021-2026) & (US$ Million) Table 153. North America Cefprozil Market Share by Country (2021-2026) Table 154. North America Cefprozil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. North America Cefprozil Market Share Forecast by Country (2027-2032) Table 156. Europe Cefprozil Market Size Growth Rate (CAGR) by Country (T): 2021 VS 2025 VS 2032 Table 157. Europe Cefprozil Sales by Country (2021-2026) & (T) Table 158. Europe Cefprozil Sales Market Share by Country (2021-2026) Table 159. Europe Cefprozil Sales Forecast by Country (2027-2032) & (T) Table 160. Europe Cefprozil Sales Market Share Forecast by Country (2027-2032) Table 161. Europe Cefprozil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Europe Cefprozil Market Size by Country (2021-2026) & (US$ Million) Table 163. Europe Cefprozil Market Share by Country (2021-2026) Table 164. Europe Cefprozil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Europe Cefprozil Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Cefprozil Market Size Growth Rate (CAGR) by Country (T): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Cefprozil Sales by Country (2021-2026) & (T) Table 168. Asia-Pacific Cefprozil Sales Market Share by Country (2021-2026) Table 169. Asia-Pacific Cefprozil Sales Forecast by Country (2027-2032) & (T) Table 170. Asia-Pacific Cefprozil Sales Market Share Forecast by Country (2027-2032) Table 171. Asia-Pacific Cefprozil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Asia-Pacific Cefprozil Market Size by Country (2021-2026) & (US$ Million) Table 173. Asia-Pacific Cefprozil Market Share by Country (2021-2026) Table 174. Asia-Pacific Cefprozil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Asia-Pacific Cefprozil Market Share Forecast by Country (2027-2032) Table 176. Latin America Cefprozil Market Size Growth Rate (CAGR) by Country (T): 2021 VS 2025 VS 2032 Table 177. Latin America Cefprozil Sales by Country (2021-2026) & (T) Table 178. Latin America Cefprozil Sales Market Share by Country (2021-2026) Table 179. Latin America Cefprozil Sales Forecast by Country (2027-2032) & (T) Table 180. Latin America Cefprozil Sales Market Share Forecast by Country (2027-2032) Table 181. Latin America Cefprozil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Latin America Cefprozil Market Size by Country (2021-2026) & (US$ Million) Table 183. Latin America Cefprozil Market Share by Country (2021-2026) Table 184. Latin America Cefprozil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Latin America Cefprozil Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Cefprozil Market Size Growth Rate (CAGR) by Country (T): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Cefprozil Sales by Country (2021-2026) & (T) Table 188. Middle East and Africa Cefprozil Sales Market Share by Country (2021-2026) Table 189. Middle East and Africa Cefprozil Sales Forecast by Country (2027-2032) & (T) Table 190. Middle East and Africa Cefprozil Sales Market Share Forecast by Country (2027-2032) Table 191. Middle East and Africa Cefprozil Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Middle East and Africa Cefprozil Market Size by Country (2021-2026) & (US$ Million) Table 193. Middle East and Africa Cefprozil Market Share by Country (2021-2026) Table 194. Middle East and Africa Cefprozil Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Middle East and Africa Cefprozil Market Share Forecast by Country (2027-2032) Table 196. Key Raw Materials Table 197. Raw Materials Key Suppliers Table 198. Cefprozil Distributors List Table 199. Cefprozil Customers List Table 200. Research Programs/Design for This Report Table 201. Authors List of This Report Table 202. Secondary Sources Table 203. Primary Sources List of Figures Figure 1. Cefprozil Image Figure 2. Global Cefprozil Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cefprozil Market Size (2021-2032) & (US$ Million) Figure 4. Global Cefprozil Sales (2021-2032) & (T) Figure 5. Anhydrous Image Figure 6. Global Anhydrous Sales YoY Growth (2021-2032) & (T) Figure 7. Monohydrate Image Figure 8. Global Monohydrate Sales YoY Growth (2021-2032) & (T) Figure 9. Global Cefprozil Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cefprozil Market Share by Type 2025 VS 2032 Figure 11. North America Cefprozil Sales Market Share in Volume by Type in 2025 Figure 12. North America Cefprozil Sales Market Share in Value by Type in 2025 Figure 13. Europe Cefprozil Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cefprozil Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cefprozil Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cefprozil Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cefprozil Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cefprozil Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cefprozil Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cefprozil Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cefprozil Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharyngitis or tonsillitis Image Figure 24. Global Pharyngitis or tonsillitis Sales YoY Growth (2021-2032) & (T) Figure 25. Otitis Media Image Figure 26. Global Otitis Media Sales YoY Growth (2021-2032) & (T) Figure 27. Acute Sinusitis Image Figure 28. Global Acute Sinusitis Sales YoY Growth (2021-2032) & (T) Figure 29. Secondary Bacterial Infection Image Figure 30. Global Secondary Bacterial Infection Sales YoY Growth (2021-2032) & (T) Figure 31. Uncomplicated Skin Image Figure 32. Global Uncomplicated Skin Sales YoY Growth (2021-2032) & (T) Figure 33. Other Image Figure 34. Global Other Sales YoY Growth (2021-2032) & (T) Figure 35. Global Cefprozil Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Cefprozil Market Share by Application 2025 VS 2032 Figure 37. North America Cefprozil Sales Market Share in Volume by Application in 2025 Figure 38. North America Cefprozil Sales Market Share in Value by Application in 2025 Figure 39. Europe Cefprozil Sales Market Share in Volume by Application in 2025 Figure 40. Europe Cefprozil Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Cefprozil Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Cefprozil Sales Market Share in Value by Application in 2025 Figure 43. Latin America Cefprozil Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Cefprozil Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Cefprozil Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Cefprozil Sales Market Share in Value by Application in 2025 Figure 47. North America Cefprozil Sales by Country: 2021 VS 2025 VS 2032 (T) Figure 48. North America Cefprozil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Cefprozil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Cefprozil Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Cefprozil Sales by Country: 2021 VS 2025 VS 2032 (T) Figure 52. Europe Cefprozil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Cefprozil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Cefprozil Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Cefprozil Sales by Country: 2021 VS 2025 VS 2032 (T) Figure 56. Asia-Pacific Cefprozil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Cefprozil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Cefprozil Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Cefprozil Sales by Country: 2021 VS 2025 VS 2032 (T) Figure 60. Latin America Cefprozil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Cefprozil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Cefprozil Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Cefprozil Sales by Country: 2021 VS 2025 VS 2032 (T) Figure 64. Middle East and Africa Cefprozil Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Cefprozil Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Cefprozil Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Cefprozil Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Cefprozil Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Anhydrous
  • Monohydrate
Applications
  • Pharyngitis or tonsillitis
  • Otitis Media
  • Acute Sinusitis
  • Secondary Bacterial Infection
  • Uncomplicated Skin
  • Other
Companies covered
  • Orchid
  • Taj Pharma
  • Dhanuka
  • Lupin
  • Alkem
  • Corden Pharma
  • Aurobindo
  • Covalent
  • TEVA GROUP
  • Hetero Drugs
  • Qilu Antibiotics
  • Dongying Pharma
  • Union Chempharma
  • Huafangpharm
  • Topfond

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cefprozil Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cefprozil Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cefprozil Market by Type
  6. 1.3.1 Anhydrous
  7. 1.3.2 Monohydrate
  8. 1.4 Global Cefprozil Market Size by Type
  9. 1.4.1 Global Cefprozil Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cefprozil Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cefprozil Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cefprozil Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cefprozil Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cefprozil Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cefprozil Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cefprozil Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cefprozil Industry Trends
  2. 2.2 Cefprozil Industry Drivers
  3. 2.3 Cefprozil Industry Opportunities and Challenges
  4. 2.4 Cefprozil Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cefprozil Revenue (2021-2026)
  2. 3.2 Global Top Players by Cefprozil Sales (2021-2026)
  3. 3.3 Global Top Players by Cefprozil Price (2021-2026)
  4. 3.4 Global Cefprozil Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cefprozil Major Company Production Sites & Headquarters
  6. 3.6 Global Cefprozil Company, Product Type & Application
  7. 3.7 Global Cefprozil Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cefprozil Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cefprozil Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cefprozil Tier 1, Tier 2, and Tier 3
4 Cefprozil Regional Status and Outlook
  1. 4.1 Global Cefprozil Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cefprozil Historic Market Size by Region
  3. 4.2.1 Global Cefprozil Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cefprozil Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cefprozil Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cefprozil Forecasted Market Size by Region
  7. 4.3.1 Global Cefprozil Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cefprozil Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cefprozil Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cefprozil by Application
  1. 5.1 Cefprozil Market by Application
  2. 5.1.1 Pharyngitis or tonsillitis
  3. 5.1.2 Otitis Media
  4. 5.1.3 Acute Sinusitis
  5. 5.1.4 Secondary Bacterial Infection
  6. 5.1.5 Uncomplicated Skin
  7. 5.1.6 Other
  8. 5.2 Global Cefprozil Market Size by Application
  9. 5.2.1 Global Cefprozil Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Cefprozil Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Cefprozil Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Cefprozil Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Cefprozil Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Cefprozil Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Cefprozil Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Cefprozil Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Orchid
  2. 6.1.1 Orchid Company Information
  3. 6.1.2 Orchid Business Overview
  4. 6.1.3 Orchid Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Orchid Cefprozil Product Portfolio
  6. 6.1.5 Orchid Recent Developments
  7. 6.2 Taj Pharma
  8. 6.2.1 Taj Pharma Company Information
  9. 6.2.2 Taj Pharma Business Overview
  10. 6.2.3 Taj Pharma Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Taj Pharma Cefprozil Product Portfolio
  12. 6.2.5 Taj Pharma Recent Developments
  13. 6.3 Dhanuka
  14. 6.3.1 Dhanuka Company Information
  15. 6.3.2 Dhanuka Business Overview
  16. 6.3.3 Dhanuka Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Dhanuka Cefprozil Product Portfolio
  18. 6.3.5 Dhanuka Recent Developments
  19. 6.4 Lupin
  20. 6.4.1 Lupin Company Information
  21. 6.4.2 Lupin Business Overview
  22. 6.4.3 Lupin Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Lupin Cefprozil Product Portfolio
  24. 6.4.5 Lupin Recent Developments
  25. 6.5 Alkem
  26. 6.5.1 Alkem Company Information
  27. 6.5.2 Alkem Business Overview
  28. 6.5.3 Alkem Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Alkem Cefprozil Product Portfolio
  30. 6.5.5 Alkem Recent Developments
  31. 6.6 Corden Pharma
  32. 6.6.1 Corden Pharma Company Information
  33. 6.6.2 Corden Pharma Business Overview
  34. 6.6.3 Corden Pharma Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Corden Pharma Cefprozil Product Portfolio
  36. 6.6.5 Corden Pharma Recent Developments
  37. 6.7 Aurobindo
  38. 6.7.1 Aurobindo Company Information
  39. 6.7.2 Aurobindo Business Overview
  40. 6.7.3 Aurobindo Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aurobindo Cefprozil Product Portfolio
  42. 6.7.5 Aurobindo Recent Developments
  43. 6.8 Covalent
  44. 6.8.1 Covalent Company Information
  45. 6.8.2 Covalent Business Overview
  46. 6.8.3 Covalent Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Covalent Cefprozil Product Portfolio
  48. 6.8.5 Covalent Recent Developments
  49. 6.9 TEVA GROUP
  50. 6.9.1 TEVA GROUP Company Information
  51. 6.9.2 TEVA GROUP Business Overview
  52. 6.9.3 TEVA GROUP Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 TEVA GROUP Cefprozil Product Portfolio
  54. 6.9.5 TEVA GROUP Recent Developments
  55. 6.10 Hetero Drugs
  56. 6.10.1 Hetero Drugs Company Information
  57. 6.10.2 Hetero Drugs Business Overview
  58. 6.10.3 Hetero Drugs Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hetero Drugs Cefprozil Product Portfolio
  60. 6.10.5 Hetero Drugs Recent Developments
  61. 6.11 Qilu Antibiotics
  62. 6.11.1 Qilu Antibiotics Company Information
  63. 6.11.2 Qilu Antibiotics Business Overview
  64. 6.11.3 Qilu Antibiotics Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Qilu Antibiotics Cefprozil Product Portfolio
  66. 6.11.5 Qilu Antibiotics Recent Developments
  67. 6.12 Dongying Pharma
  68. 6.12.1 Dongying Pharma Company Information
  69. 6.12.2 Dongying Pharma Business Overview
  70. 6.12.3 Dongying Pharma Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dongying Pharma Cefprozil Product Portfolio
  72. 6.12.5 Dongying Pharma Recent Developments
  73. 6.13 Union Chempharma
  74. 6.13.1 Union Chempharma Company Information
  75. 6.13.2 Union Chempharma Business Overview
  76. 6.13.3 Union Chempharma Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Union Chempharma Cefprozil Product Portfolio
  78. 6.13.5 Union Chempharma Recent Developments
  79. 6.14 Huafangpharm
  80. 6.14.1 Huafangpharm Company Information
  81. 6.14.2 Huafangpharm Business Overview
  82. 6.14.3 Huafangpharm Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Huafangpharm Cefprozil Product Portfolio
  84. 6.14.5 Huafangpharm Recent Developments
  85. 6.15 Topfond
  86. 6.15.1 Topfond Company Information
  87. 6.15.2 Topfond Business Overview
  88. 6.15.3 Topfond Cefprozil Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Topfond Cefprozil Product Portfolio
  90. 6.15.5 Topfond Recent Developments
7 North America by Country
  1. 7.1 North America Cefprozil Sales by Country
  2. 7.1.1 North America Cefprozil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cefprozil Sales by Country (2021-2026)
  4. 7.1.3 North America Cefprozil Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cefprozil Market Size by Country
  6. 7.2.1 North America Cefprozil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cefprozil Market Size by Country (2021-2026)
  8. 7.2.3 North America Cefprozil Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cefprozil Sales by Country
  2. 8.1.1 Europe Cefprozil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cefprozil Sales by Country (2021-2026)
  4. 8.1.3 Europe Cefprozil Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cefprozil Market Size by Country
  6. 8.2.1 Europe Cefprozil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cefprozil Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cefprozil Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cefprozil Sales by Country
  2. 9.1.1 Asia-Pacific Cefprozil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cefprozil Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cefprozil Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cefprozil Market Size by Country
  6. 9.2.1 Asia-Pacific Cefprozil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cefprozil Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cefprozil Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cefprozil Sales by Country
  2. 10.1.1 South America Cefprozil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cefprozil Sales by Country (2021-2026)
  4. 10.1.3 South America Cefprozil Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cefprozil Market Size by Country
  6. 10.2.1 South America Cefprozil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cefprozil Market Size by Country (2021-2026)
  8. 10.2.3 South America Cefprozil Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cefprozil Sales by Country
  2. 11.1.1 Middle East and Africa Cefprozil Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cefprozil Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cefprozil Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cefprozil Market Size by Country
  6. 11.2.1 Middle East and Africa Cefprozil Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cefprozil Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cefprozil Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cefprozil Value Chain Analysis
  2. 12.1.1 Cefprozil Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cefprozil Production Mode & Process
  7. 12.2 Cefprozil Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cefprozil Distributors
  10. 12.2.3 Cefprozil Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst